It's official: 2017 is the largest year yet for digital health funding. But beyond the notable $4.7B invested so far, a number of interesting trends emerged. Get a sneak peek below and read our analysis of where digital health is today in our Q3 2017 Funding Update.
- The biggest deal of the quarter—and the only one over $100M—went to a little company called 23andMe as it made a shift we’re seeing companies across digital health make: from B2C to B2B.
- Compared to previous years, we saw greater alignment between where venture dollars are going and where they’re getting returned—particularly with EHR/clinical workflow and consumer engagement categories.
- There may be no digital health IPOs in 2017. M&A has slowed as well—leaving investors oscillating between feeling frustration and preaching patience.
- A heartening metric: 16% of companies funded in Q3 are led by women CEOs. While there is still a long ways to climb, it's a significant increase from the 11% (and lower) female representation persisting in previous years.
Each year we recognize fifty of the leading entrepreneurs, technologists, reporters, and providers making huge impacts in health innovation. We can't do it without you. Nominations for this year's Top 50 in Digital Health are now open.
You have less than a week to apply for the 2017 Aging in Place $50K Challenge! Tell us how your startup is improving the lives of older Americans for a chance to win $50K from AARP Foundation. Submissions close this Friday, 10/6.
- Groupon cofounder's startup Tempus closed $70M for its clinical and molecular database
- Clinical workflow company PatientSafe Solutions closed a $25M growth round
- Surgical analytics company Caresyntax nabbed $11.9M
- Mayo Clinic startup Qrativ launched with $8.3M to mine data for rare disease treatments
- Cardinal Analytyx got $6.1M for its cost prediction tool
- Austin-based Iris Plans, a remote advanced care planning service, gets $5.1M